Therapy News and Research

RSS

Effectiveness of mRNA vaccines, antibody treatment reduced by all three omicron subvariants

Only one currently authorized antibody treatment retains its activity against all Omicron subvariants, according to new research by scientists at Columbia University and the University of Hong Kong.

3 Mar 2022

Choice of initial treatment not related to depression, emotional well-being in prostate cancer patients

Depression and other mental health outcomes are similar for men choosing different options for initial treatment of localized prostate cancer, reports a study in The Journal of Urology, an Official Journal of the American Urological Association.

3 Mar 2022

Improvements needed in diagnosis and treatment of people with prediabetes, study says

According to the U.S. Centers for Disease Control and Prevention, prediabetes is a serious health condition in which blood sugar levels are higher than normal, but not high enough to meet the threshold for type 2 diabetes.

3 Mar 2022

Clinical trial report endorses nitazoxanide as a safe drug for moderately ill COVID-19 patients

Researchers tested the safety and efficacy of 600 mg oral dose of nitazoxanide in mild or moderately ill COVID-19 patients.

3 Mar 2022

Convalescent plasma therapy shows no significant impact on COVID-19 recovery and outcomes

Researchers conduct a multi-center study involving hospitalized COVID-19 patients to gather information on the rationale use of convalescent plasma.

3 Mar 2022

Study provides insight into what causes therapy failure in patients with myelodysplastic syndromes

Researchers from The University of Texas MD Anderson Cancer Center discovered that treatment resistance in patients with myelodysplastic syndromes (MDS) is caused by two distinct classes of stem cells and identified possible therapeutic approaches that target these cells.

3 Mar 2022

Study shows targeting DDX3 with RK-33 reduced the viral load in four isolates of SARS-CoV-2

A new study has focused on developing a novel anti-SARS-CoV-2 therapy using HTA directed against the human host DEAD-box RNA helicase.

3 Mar 2022

Identifying and managing drug-drug interactions key to the safe use of nirmatrelvir–ritonavir in COVID-19 treatment

Researchers compiled evidence-based recommendations in consultation with European and North American clinicians and pharmacologists for recognizing and managing drug-drug interactions with nirmatrelvir–ritonavir.

3 Mar 2022

Novel approach to generate reliable breast tumor models may pave way for better immunotherapies

The discrepancy between preclinical advances in breast cancer immunotherapy and poor patient outcomes is rooted in the limitations of current breast cancer models. These models often fail to mimic complex interactions between cancer cells and key immune cells present in the tumor microenvironment.

3 Mar 2022

HIV preventive care is supposed to be free in the US. so, why are some patients still paying?

Anthony Cantu, 31, counsels patients at a San Antonio health clinic about a daily pill shown to prevent HIV infection.

3 Mar 2022

Researchers propose potential fixes to develop evidence-based diagnostic criteria for FMDs

Functional Movement Disorders (FMDs) are common and disabling conditions. With an increasing research interest in FMDs, including the emergence of intervention trials, it is crucial to examine research methodology and develop standardized protocols.

2 Mar 2022

Nicotinamide riboside supplement shows promise as a potential therapy for Parkinson’s disease

Nicotinamide riboside (NR) is amember of the vitamin B3 family, which can be found in foods like fruits, vegetables, meat, and milk. It is also used as a nutritional supplement to boost cellular levels of NAD (nicotinamide adenine dinucleotide).

2 Mar 2022

Australian bull ants' venom component exploits a pain pathway in mammals

Australian bull ants have evolved a venom molecule perfectly tuned to target one of their predators – the echidna – that also could have implications for people with long-term pain, University of Queensland researchers say.

2 Mar 2022

Study suggests link between sleep apnea and joint pain in postmenopausal women

The menopause transition is associated with several health issues. The incidence of both sleep apnea and joint pain, for example, are higher in postmenopausal women.

2 Mar 2022

Triple drug regimen proven effective against non-structural protein-1 of SARS-CoV-2

Researchers evaluated the synergistic activity of drugs acting against non-structural protein 1 of SARS-CoV-2 to decrease the viral infectivity.

2 Mar 2022

To be one in a million: ‘Who thinks it’s going to be you?’

Monica Melkonian wanted the Johnson & Johnson covid vaccine. It was only one shot and then she would be protected against the virus. So she was thrilled when the vaccination clinic at the Deschutes County Fair & Expo Center on April 7 had her first choice.

2 Mar 2022

Government invests £260 million to support health research and life sciences manufacturing

Patients across the country are set to benefit from cutting-edge medical advances and treatments as the government invests £260 million today (Wednesday 2 March) to support research and development, as well as the manufacturing of new drugs, devices and diagnostics.

2 Mar 2022

Targeting necroptosis using a necroptosis inhibitor lessens myositis-induced muscle weakness

A new study has suggested that treatment to target necroptosis in muscle fibers using a necroptosis inhibitor lessens myositis-induced muscle weakness as well as muscle cell death and inflammation in the muscles. This has been shown to be a promising strategy for treating polymyositis.

2 Mar 2022

Research sheds light on the role of lipids in Alzheimer’s disease development

Neurons in the brain coexist with and rely on many other cell types to function properly. Astrocytes, which take their name from their star shape, ensure the survival of neurons by feeding and detoxifying them with the help of a multifunctional protein, APOE.

1 Mar 2022

Cleveland Clinic launches new study exploring the link between epilepsy and stress

Cleveland Clinic has launched an innovative study exploring the link between epilepsy and stress, supported by a $5.5 million donation from the Charles L. Shor Foundation.

1 Mar 2022

Therapy News and Research

Effectiveness of mRNA vaccines, antibody treatment reduced by all three omicron subvariants

Choice of initial treatment not related to depression, emotional well-being in prostate cancer patients

Improvements needed in diagnosis and treatment of people with prediabetes, study says

Clinical trial report endorses nitazoxanide as a safe drug for moderately ill COVID-19 patients

Convalescent plasma therapy shows no significant impact on COVID-19 recovery and outcomes

Study provides insight into what causes therapy failure in patients with myelodysplastic syndromes

Study shows targeting DDX3 with RK-33 reduced the viral load in four isolates of SARS-CoV-2

Identifying and managing drug-drug interactions key to the safe use of nirmatrelvir–ritonavir in COVID-19 treatment

Novel approach to generate reliable breast tumor models may pave way for better immunotherapies

HIV preventive care is supposed to be free in the US. so, why are some patients still paying?

Researchers propose potential fixes to develop evidence-based diagnostic criteria for FMDs

Nicotinamide riboside supplement shows promise as a potential therapy for Parkinson’s disease

Australian bull ants' venom component exploits a pain pathway in mammals

Study suggests link between sleep apnea and joint pain in postmenopausal women

Triple drug regimen proven effective against non-structural protein-1 of SARS-CoV-2

To be one in a million: ‘Who thinks it’s going to be you?’

Government invests £260 million to support health research and life sciences manufacturing

Targeting necroptosis using a necroptosis inhibitor lessens myositis-induced muscle weakness

Research sheds light on the role of lipids in Alzheimer’s disease development

Cleveland Clinic launches new study exploring the link between epilepsy and stress

Industry Focus eBook - Cell biology (5th edition) eBook

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News